Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 1 (January)

1. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
   Am J Surg Pathol, 31(1): 26-32. [Abstract] [Full-text]
2. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.
   ScientificWorldJournal, 6: 1705-12. [Abstract] [Full-text]
3. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.
   J Thorac Cardiovasc Surg, 133(1): 104-10. [Abstract] [Full-text]
4. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
   J Surg Oncol, 95(1): 63-9. [Abstract] [Full-text]
5. Statins and the risk of lung, breast, and colorectal cancer in the elderly.
   Circulation, 115(1): 27-33. [Abstract] [Full-text]
6. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo.
   Biochem Biophys Res Commun, 353(2): 418-23. [Abstract] [Full-text]
7. HDJC9, a novel human type C DnaJ/HSP40 member interacts with and cochaperones HSP70 through the J domain.
   Biochem Biophys Res Commun, 353(2): 280-5. [Abstract] [Full-text]
8. A five-gene signature and clinical outcome in non-small-cell lung cancer.
   N Engl J Med, 356(1): 11-20. [Abstract] [Full-text]
9. Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
   Clin Chem, 53(1): 53-61. [Abstract] [Full-text]
10. Detection of epidermal growth factor receptor variations by partially denaturing HPLC.
    Clin Chem, 53(1): 62-70. [Abstract] [Full-text]
11. PET/CT in non-small cell lung cancer staging-promises and problems.
    Clin Radiol, 62(2): 97-108. [Abstract] [Full-text]
12. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.
    Cancer Res, 67(1): 93-9. [Abstract] [Full-text]
13. Microsatellite instability is uncommon in lymphoepithelioma-like carcinoma of the lung.
    Am J Clin Pathol, 127(2): 282-6. [Abstract] [Full-text]
14. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.
    Am J Clin Pathol, 127(2): 254-62. [Abstract] [Full-text]
15. Prognostic factors in pleuro-pulmonary blastoma.
    Pediatr Blood Cancer, 48(3): 318-23. [Abstract] [Full-text]
16. Evidence that MIG-6 is a tumor-suppressor gene.
    Oncogene, 26(2): 269-76. [Abstract] [Full-text]
17. Malignant small round cell tumor of the heart: a diagnostic dilemma.
    Cardiovasc Pathol, 16(1): 56-8. [Abstract] [Full-text]
18. 5-Bromodeoxyuridine induced differentiation of a human small cell lung cancer cell line is associated with alteration of gene expression.
    Biochem Biophys Res Commun, 353(3): 559-64. [Abstract] [Full-text]
19. Radon and lung cancer risk: an extension of the mortality follow-up of the Newfoundland fluorspar cohort.
    Health Phys, 92(2): 157-69. [Abstract] [Full-text]
20. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma.
    Arch Surg, 142(1): 70-5; discission 76. [Abstract] [Full-text]
21. Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy.
    Cancer Chemother Pharmacol, 59(4): 429-37. [Abstract] [Full-text]
22. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).
    Cancer Chemother Pharmacol, 59(4): 507-13. [Abstract] [Full-text]
23. Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.
    Cancer Chemother Pharmacol, 59(4): 419-27. [Abstract] [Full-text]
24. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    J Clin Oncol, 25(3): 313-8. [Abstract] [Full-text]
25. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
    Hum Pathol, 38(2): 220-7. [Abstract] [Full-text]
26. Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.
    Cancer Sci, 98(2): 246-52. [Abstract] [Full-text]
27. Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer.
    Cancer Sci, 98(2): 226-30. [Abstract] [Full-text]
28. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
    Cancer Sci, 98(2): 169-73. [Abstract] [Full-text]
29. Desmoglein 3 as a prognostic factor in lung cancer.
    Hum Pathol, 38(2): 276-83. [Abstract] [Full-text]
30. DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation.
    Hum Pathol, 38(2): 260-8. [Abstract] [Full-text]
31. Microvesicle-associated tissue factor and Trousseau's syndrome.
    J Thromb Haemost, 5(1): 70-4. [Abstract] [Full-text]
32. Application of adenosine 5'-triphosphate (ATP) infusions in palliative home care: design of a randomized clinical trial.
    BMC Public Health, 7: 4. [Abstract] [Full-text]
33. A model for predicting lung cancer response to therapy.
    Int J Radiat Oncol Biol Phys, 67(2): 601-9. [Abstract] [Full-text]
34. PDGFR-beta expression in small cell lung cancer patients.
    Int J Radiat Oncol Biol Phys, 67(2): 431-7. [Abstract] [Full-text]
35. Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography.
    Int J Radiat Oncol Biol Phys, 67(2): 417-24. [Abstract] [Full-text]
36. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
    Int J Radiat Oncol Biol Phys, 67(2): 410-6. [Abstract] [Full-text]
37. Long-term results of endobronchial brachytherapy: A curative treatment?
    Int J Radiat Oncol Biol Phys, 67(2): 425-30. [Abstract] [Full-text]
38. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.
    Clin Nucl Med, 32(2): 101-5. [Abstract] [Full-text]
39. [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias.
    Arch Intern Med, 167(2): 161-5. [Abstract] [Full-text]
40. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer.
    AJR Am J Roentgenol, 188(2): 318-25. [Abstract] [Full-text]
41. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology.
    AJR Am J Roentgenol, 188(2): 306-12. [Abstract] [Full-text]
42. Chronic arsenic poisoning: a global health issue -- a report of multiple primary cancers.
    J Cutan Pathol, 34(2): 203-6. [Abstract] [Full-text]
43. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.
    Cancer, 109(3): 581-7. [Abstract] [Full-text]
44. 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer.
    Cancer, 109(3): 574-80. [Abstract] [Full-text]
45. Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors.
    Int J Cancer, 120(5): 1150-3. [Abstract] [Full-text]
46. Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lung.
    Int J Cancer, 120(5): 1055-62. [Abstract] [Full-text]
47. Dietary zinc, copper and selenium, and risk of lung cancer.
    Int J Cancer, 120(5): 1108-15. [Abstract] [Full-text]
48. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Radiology, 242(2): 555-62. [Abstract] [Full-text]
49. Lung carcinoma in African Americans.
    Nat Clin Pract Oncol, 4(2): 118-29. [Abstract] [Full-text]
50. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
    J Thorac Cardiovasc Surg, 133(2): 352-63. [Abstract] [Full-text]
51. Data acquisition for the histoculture drug response assay in lung cancer.
    J Thorac Cardiovasc Surg, 133(2): 303-8. [Abstract] [Full-text]
52. Transcleral orbital invasion by a radiation and chemotherapy-resistant choroidal metastasis of a pulmonary adenocarcinoma.
    Am J Ophthalmol, 143(2): 369-70. [Abstract] [Full-text]
53. Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung.
    Ann Thorac Surg, 83(2): 687-9. [Abstract] [Full-text]
54. Effective symptomatic relief of hypertrophic pulmonary osteoarthropathy by video-assisted thoracic surgery truncal vagotomy.
    Ann Thorac Surg, 83(2): 684-5. [Abstract] [Full-text]
55. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Ann Thorac Surg, 83(2): 419-24. [Abstract] [Full-text]
56. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.
    Ann Thorac Surg, 83(2): 409-17; discussioin 417-8. [Abstract] [Full-text]
57. Flexible videopericardioscopy in cT4 nonsmall-cell lung cancer with radiologic evidence of proximal vascular invasion.
    Ann Thorac Surg, 83(2): 402-8. [Abstract] [Full-text]
58. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Ann Thorac Surg, 83(2): 397-400. [Abstract] [Full-text]
59. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.
    J Clin Oncol, 25(4): 418-23. [Abstract] [Full-text]
60. Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.
    Nucl Med Commun, 28(3): 173-7. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.